- Home
- ELTX vs PETS Comparison
ELTX vs PETS Comparison
Compare ELTX & PETS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELTX
- PETS
- Stock Information
- Founded
- ELTX 2011
- PETS 1996
- Country
- ELTX United States
- PETS United States
- Employees
- ELTX N/A
- PETS N/A
- Industry
- ELTX Biotechnology: Pharmaceutical Preparations
- PETS Retail-Drug Stores and Proprietary Stores
- Sector
- ELTX Health Care
- PETS Consumer Staples
- Exchange
- ELTX Nasdaq
- PETS Nasdaq
- Market Cap
- ELTX 49.7M
- PETS 82.0M
- IPO Year
- ELTX 2021
- PETS N/A
- Fundamental
- Price
- ELTX $4.16
- PETS $4.07
- Analyst Decision
- ELTX Buy
- PETS Sell
- Analyst Count
- ELTX 2
- PETS 2
- Target Price
- ELTX $10.00
- PETS $3.50
- AVG Volume (30 Days)
- ELTX 16.1K
- PETS 182.6K
- Earning Date
- ELTX 11-07-2024
- PETS 11-06-2024
- Dividend Yield
- ELTX N/A
- PETS 29.41%
- EPS Growth
- ELTX N/A
- PETS N/A
- EPS
- ELTX N/A
- PETS N/A
- Revenue
- ELTX N/A
- PETS $270,772,000.00
- Revenue This Year
- ELTX N/A
- PETS N/A
- Revenue Next Year
- ELTX N/A
- PETS $3.27
- P/E Ratio
- ELTX N/A
- PETS N/A
- Revenue Growth
- ELTX N/A
- PETS 2.26
- 52 Week Low
- ELTX $2.96
- PETS $2.90
- 52 Week High
- ELTX $11.45
- PETS $8.27
- Technical
- Relative Strength Index (RSI)
- ELTX 40.82
- PETS 56.76
- Support Level
- ELTX $4.05
- PETS $3.78
- Resistance Level
- ELTX $4.89
- PETS $4.17
- Average True Range (ATR)
- ELTX 0.28
- PETS 0.18
- MACD
- ELTX -0.06
- PETS -0.01
- Stochastic Oscillator
- ELTX 27.37
- PETS 62.22
About ELTX Elicio Therapeutics Inc.
Elicio Therapeutics Inc is a clinical-stage biotechnology company pioneering the development of cancer immunotherapies for patients with limited treatment options and poor outcomes. Its proprietary Amphiphile, or AMP, platform delivers investigational immunotherapeutics directly to the brain center of the immune system the lymph nodes. Its focus is the development of cancer immunotherapies against biologically validated but hard-to-drug targets that can be activated through lymph node trafficking. Elicio is engineering lymph node-targeted AMPlifiers, immunomodulators, adjuvants, and vaccines for an array of aggressive cancers. It has developed its cancer vaccine product candidates to target biologically validated tumor mutation drivers using known neoantigens.
About PETS PetMed Express Inc.
PetMed Express Inc along with its subsidiaries is a nationwide pet pharmacy. The company markets prescription and non-prescription pet medications, health products, and supplies for dogs and cats, direct to the consumer. The company generates its revenue by selling pet medications and pet supplies mainly to retail consumers.